Open-Label Safety Extension Study of Avonex

Clinical trial NCT00915460 · COMPLETED

Trial details

NCT number: NCT00915460
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 1999-09-01
Primary completion: 2003-06-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.